Insider sale
VIR BIOTECHNOLOGY, INC.
$14.47M
2.40M shares
SVF ENDURANCE (CAYMAN) LTD plans to sell 2.40M shares of VIR BIOTECHNOLOGY, INC. valued at approximately $14.47M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Acquired upon the automatic conversion of convertible preferred stock. The convertible preferred stock was acquired and fully paid for in multiple transactions from August 2017 to January 2019.
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/16/2019 | Acquired upon the automatic conversion of convertible preferred stock. The convertible preferred stock was acquired and fully paid for in multiple transactions from August 2017 to January 2019. Cash | 21.67M | — |
| Total | 21.67M | ||
Completed
Units to sell
220.53K
Market value
$1.37M
Units to sell
12.84K
Market value
$78.4K
Units to sell
16.67K
Market value
$101.2K
Units to sell
2.30K
Market value
$14.0K
Units to sell
249.06K
Market value
$1.53M
Units to sell
466.24K
Market value
$2.82M
Units to sell
72.13K
Market value
$404.2K
Units to sell
73.95K
Market value
$420.6K
Units to sell
450.34K
Market value
$2.50M
Planned — Approximate Date
Units to sell
834.20K
Market value
$5.23M
Units
2.40M
Value
$14.47M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/20/2025 | 220.53K | $1.37M | — | Completed |
10/16/2025 | 12.84K | $78.4K | — | Completed |
10/15/2025 | 16.67K | $101.2K | — | Completed |
10/10/2025 | 2.30K | $14.0K | — | Completed |
10/9/2025 | 249.06K | $1.53M | — | Completed |
10/8/2025 | 466.24K | $2.82M | — | Completed |
10/7/2025 | 72.13K | $404.2K | — | Completed |
10/6/2025 | 73.95K | $420.6K | — | Completed |
10/3/2025 | 450.34K | $2.50M | — | Completed |
| Planned — Approximate Date | ||||
10/21/2025 | 834.20K | $5.23M | NASDAQ | Planned |
| Total | 2.40M | $14.47M | ||